Literature DB >> 22549621

Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.

Christina E Wierenga1, Sheena I Dev, David D Shin, Lindsay R Clark, Katherine J Bangen, Amy J Jak, Robert A Rissman, Thomas T Liu, David P Salmon, Mark W Bondi.   

Abstract

Using whole-brain pulsed arterial spin labeling magnetic resonance imaging, resting cerebral blood flow (CBF) was measured in 20 mild cognitive impairment (MCI; 11 ɛ3 and 9 ɛ4) and 40 demographically matched cognitively normal (CN; 27 ɛ3 and 13 ɛ4) participants. An interaction of apolipoprotein (APOE) genotype (ɛ3 and ɛ4) and cognitive status (CN and MCI) on quantified gray-matter CBF corrected for partial volume effects was found in the left parahippocampal and fusiform gyri (PHG/FG), right middle frontal gyrus, and left medial frontal gyrus. In the PHG/FG, CBF was elevated for CN ɛ4 carriers but decreased for MCI ɛ4 carriers. The opposite pattern was seen in frontal regions: CBF was decreased for CN ɛ4 carriers but increased for MCI ɛ4 carriers. Cerebral blood flow in the PHG/FG was positively correlated with verbal memory for CN ɛ4 adults (r=0.67, P=0.01). Cerebral blood flow in the left medial frontal gyrus was positively correlated with verbal memory for MCI ɛ4 adults (r=0.70, P=0.05). Findings support dynamic pathophysiologic processes in the brain associated with Alzheimer's disease risk and indicate that cognitive status and APOE genotype have interactive effects on CBF. Correlations between CBF and verbal memory suggest a differential neurovascular compensatory response in posterior and anterior cortices with cognitive decline in ɛ4 adults.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549621      PMCID: PMC3421098          DOI: 10.1038/jcbfm.2012.58

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  45 in total

1.  Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system.

Authors:  J A Detre; D C Alsop
Journal:  Eur J Radiol       Date:  1999-05       Impact factor: 3.528

2.  A signal processing model for arterial spin labeling functional MRI.

Authors:  Thomas T Liu; Eric C Wong
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

3.  Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II).

Authors:  E C Wong; R B Buxton; L R Frank
Journal:  Magn Reson Med       Date:  1998-05       Impact factor: 4.668

Review 4.  Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease.

Authors:  R W Mahley; B P Nathan; R E Pitas
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

5.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Fractional diastolic and systolic pressure in the ascending aorta are related to the extent of coronary artery disease.

Authors:  Piotr Jankowski; Kalina Kawecka-Jaszcz; Leszek Bryniarski; Danuta Czarnecka; Magorzata Brzozowska-Kiszka; Aneta Pośnik-Urbańska; Grzegorz Kopeć; Jacek Dragan; Artur Klecha; Dariusz Dudek
Journal:  Am J Hypertens       Date:  2004-08       Impact factor: 2.689

8.  Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Authors:  P Tiraboschi; L A Hansen; E Masliah; M Alford; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

9.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Authors:  E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

10.  Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.

Authors:  R B D'Agostino; P A Wolf; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1994-01       Impact factor: 7.914

View more
  43 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Increased hippocampal blood flow in sedentary older adults at genetic risk for Alzheimer's disease.

Authors:  Zvinka Z Zlatar; Christina E Wierenga; Katherine J Bangen; Thomas T Liu; Amy J Jak
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 3.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  The Cerebral Blood Flow Biomedical Informatics Research Network (CBFBIRN) data repository.

Authors:  David D Shin; I Burak Ozyurt; Gregory G Brown; Christine Fennema-Notestine; Thomas T Liu
Journal:  Neuroimage       Date:  2015-05-30       Impact factor: 6.556

5.  Lack of Influence of Apolipoprotein E Status on Cognition or Brain Structure in Professional Fighters.

Authors:  Sarah J Banks; Justin B Miller; Robert A Rissman; Charles B Bernick
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

6.  Cigarette smoking and cerebral blood flow in a cohort of middle-aged adults.

Authors:  Martine Elbejjani; Reto Auer; Sudipto Dolui; David R Jacobs; Thaddeus Haight; David C Goff; John A Detre; Christos Davatzikos; R Nick Bryan; Lenore J Launer
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-22       Impact factor: 6.200

7.  Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; M J Meloy; Jessica Osuna; Thomas T Liu; Douglas R Galasko; Christina E Wierenga
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 8.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

9.  Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression.

Authors:  Tiffany C Ho; Jing Wu; David D Shin; Thomas T Liu; Susan F Tapert; Guang Yang; Colm G Connolly; Guido K W Frank; Jeffrey E Max; Owen Wolkowitz; Stuart Eisendrath; Fumiko Hoeft; Dipavo Banerjee; Korey Hood; Robert L Hendren; Martin P Paulus; Alan N Simmons; Tony T Yang
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-07-25       Impact factor: 8.829

10.  Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid.

Authors:  Jack T Wiedrick; Jay I Phillips; Theresa A Lusardi; Trevor J McFarland; Babett Lind; Ursula S Sandau; Christina A Harrington; Jodi A Lapidus; Douglas R Galasko; Joseph F Quinn; Julie A Saugstad
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.